top of page
Abstract Shape

  1. Kutscher LM, Aprile D, Bayin NS, Becker EBE, Cerrato V, Turrini G, Coolen M, Cantagrel V, Durand BC, Evans Ii MK, Haldipur P, Millen KJ, Yeung J, Goldowitz D, Hatten ME, Joyner AL, Kebschull JM, Li JYH, Quadrato G, Schmidt C, Sepp M, Silva TP, Testa G, Tiberi L, Mayer S. Conference Report: Cerebellar Development and Disease at Single-Cell Resolution. Cerebellum. 2025 Jun 5;24(4):109. doi: 10.1007/s12311-025-01864-5. PubMed PMID: 40471378; PubMed Central PMCID: PMC12141159.

  2. Schmidt, C.*, Cohen, S., Gudenas, BL., Husain, S., Carlson, A., Westelman, S., Wang, L., Phillips, J.J., Northcott, P.A., Weiss, W.A., Schwer, B (2024). PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression. Sci Rep. 2024 Jul 12;14(1):16074. doi: 10.1038/s41598-024-66811-6.

  3. Kuzuoglu-Ozturk, D., Aksoy, O., Schmidt, C., Lea, R., Larson, J.D., Phelps, R.R.L., Nasholm, N., Holt, M., Contreras, A., Huang, M., et al. (2023). N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma. Cancer Res. 83, 130–140. 10.1158/0008-5472.CAN-22-0945.

  4. Hahn, W.C., Bader, J.S., Braun, T.P., Califano, A., Clemons, P.A., Druker, B.J., Ewald, A.J., Fu, H., Jagu, S., Kemp, C.J., Cancer Target Discovery and Development Network, et al. (2021). An expanded universe of cancer targets. Cell 184, 1142–1155. 10.1016/j.cell.2021.02.020.

  5. Lambo, S., Gröbner, S.N., Rausch, T., Waszak, S.M., Schmidt, C., Gorthi, A., Romero, J.C., Mauermann, M., Brabetz, S., Krausert, S., et al. (2019). The molecular landscape of ETMR at diagnosis and relapse. Nature 576, 274–280. 10.1038/s41586-019-1815-x.

  6. Sabelström, H., Petri, R., Shchors, K., Jandial, R., Schmidt, C., Sacheva, R., Masic, S., Yuan, E., Fenster, T., Martinez, M., et al. (2019). Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma Aggressiveness. Cell Rep. 28, 2064-2079.e11. 10.1016/j.celrep.2019.07.071.

  7. Ilkhanizadeh, S., Sabelström, H., Miroshnikova, Y.A., Frantz, A., Zhu, W., Idilli, A., Lakins, J.N., Schmidt, C., Quigley, D.A., Fenster, T., et al. (2018). Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma. Mol. Cancer Res. 16, 777–790. 10.1158/1541-7786.MCR-17-0413.

  8. Schmidt, C.*, Schubert, N.A., Brabetz, S., Mack, N., Schwalm, B., Chan, J.A., Selt, F., Herold-Mende, C., Witt, O., Milde, T., et al. (2017). Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients. Neuro Oncol. 19, 1607–1617. 10.1093/neuonc/nox093.

  9. Brandenburg, S., Müller, A., Turkowski, K., Radev, Y.T., Rot, S., Schmidt, C., Bungert, A.D., Acker, G., Schorr, A., Hippe, A., et al. (2016). Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors. Acta Neuropathol. 131, 365–378. 10.1007/s00401-015-1529-6.

  10. Lau, J., Ilkhanizadeh, S., Wang, S., Miroshnikova, Y.A., Salvatierra, N.A., Wong, R.A., Schmidt, C., Weaver, V.M., Weiss, W.A., and Persson, A.I. (2015). STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma. Cancer Res. 75, 4302–4311. 10.1158/0008-5472.CAN-14-3331.

  11. Moreno, N.*, Schmidt, C.*, Ahlfeld, J., Pöschl, J., Dittmar, S., Pfister, S.M., Kool, M., Kerl, K., and Schüller, U. (2014). Loss of Smarc proteins impairs cerebellar development. J. Neurosci. 34, 13486–13491. 10.1523/JNEUROSCI.2560-14.2014.

  12. Kool, M., Jones, D.T.W., Jäger, N., Northcott, P.A., Pugh, T.J., Hovestadt, V., Piro, R.M., Esparza, L.A., Markant, S.L., Remke, M., Schmidt, C., et al. (2014). Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25, 393–405. 10.1016/j.ccr.2014.02.004.

  13. Lau, J., Schmidt, C., Markant, S.L., Taylor, M.D., Wechsler-Reya, R.J., and Weiss, W.A. (2012). Matching mice to malignancy: molecular subgroups and models of medulloblastoma. Childs Nerv Syst 28, 521–532. 10.1007/s00381-012-1704-1.

bottom of page